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ABSTRACT: Expressions for prevalence (P) and incidence (I) in open dynamic 
populations are derived. When screenings are performed every s:th year, P and I will 
be functions of s. It is shown how the true values of P and l, which would have been 
obtained with continuous screening, can be estimated from screening data. A solution 
is also given to the following problem: Given that subsets of the population have 
different P's and I's and that resources are limited so only a fraction of the total 
population can be screened every year, which should be screened and how often in 
order to maximize the total proportion of detected cases? 
KEY WORDS: Epidemiology, open dynamic population, prevalence, incidence, 
screening, optimality. 
1. Introduction 
The epidemiological characterization of a disease in a population is often 
expressed in terms of prevalence (P) and incidence (1). In an open dynamic 
population, P refers to the proportion of diseased individuals at a given point 
in time whereas I refers to the rate of new ocurrences of the disease. These 
concepts, which reflect the collective actual health state in a population, 
should not be confused with individual risk measures like probability and 
hazard of developing the disease, as will be made clear below. 
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Periodic health controls or screenings can be effective for early detection 
of diseases, and data from screenings can be used to estimate P and I. This 
will be of special importance in countries where routines for collecting 
medical data is less developed, or for diseases which rarely can be detected 
by the patients, such as diabetic retinopathy (cf. [SUS 82]). Here, an 
unknown number of never detected cases is to be expected if not screenings 
are performed. 
In this paper expressions for P and I will be presented for non-recurrent 
diseases, which allows an arbitrary proportion of the population to be 
recovered from the disease. Similar expressions have been derived earlier 
under the assumptions that there is no recovery from the disease and that the 
disease shortens the remaining life time of the individual [ALH 92]. This 
may be true for some diseases, but it is not generally true for breast cancer, 
thigh-bone fractures, venereal diseases or schizophrenia, to mention a few 
examples. For diseases which can only be detected at screenings performed 
every s:th year, P and I will be functions of s, P(s) and I(s). These screening-
related measures tend to zero as s~oo and to P and I, the values which would 
have been obtained with continuous screening, as s~O. The differences 
between P and P(s) and between I and I(s) can be used to judge the benefit of 
a screening program beynd other measures such as lead time, i e. the time by 
which the diagnosis is advanced by screening [ZEL 69]. The screening-
related measures can also be used to find an optimal solution of the following 
problem: Given that subsets of the population have different P's and I's and 
that resources are limited so only a fraction of the population can be screened 
every year, which shall be screened and how often? These results will be 
applied, using data from a screening study for diabetic retinopathy in 
Sweden. 
2. Notations and assumptions 
In an open dynamic population P and I is composed of four components: 
(1) 'A, the intensity by which the individuals enter the population, (2) the 
distribution of T, the period each individual spend in the population, (3) the 
distribution of Z, the time from the entrance into the population until the 
onset of the disease and (4) the distribution of R, the duration of the disease. 
'A and T is typically interpreted as birth rate and life time, respectively, but 
other interpretations are possible. For diseases which are exclusively 
subjected to patients with diabetes, 'A is the rate of new cases of diabetes and 
T is the duration of the diabetes. 
The following assumptions are made about the components:(l) 'A is the 
constant intensity of a stationary Poisson process. This assumption will make 
P and I independent of 'A. (2) T is a random variable with a continuous 
cumulative distribution function (cdf) F.J..x) and survival function (sf) 
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SrCx)=1-FrCx). (3) Zhas the cdf Fz(x)=1-Sz(x) which may have discrete steps 
and Fz ( 00 ) < 1 is the proportion of the population which eventually is 
diseased. (4) The duration R is allowed to depend on Z with conditional sf 
SR (xiz) = peR > xlZ = z). A well-known example of the latter dependency 
is recovery from thigh-bone fracture which tends to take a longer time for 
elderly patients. Diseases which may cause, or at least are associated with 
factors which may cause the individuals death, will for convenience be called 
mortal. Diseases without the latter property are called non-mortal. The 
distinction will be of importance for P but not for 1. The actual time each 
individual spend in the population is thus min(T, Z+R) for mortal diseases 
and T for non-mortal diseases. In the latter case R can be interpreted "as time 
to recovery" and when no recovery is possible SR (xlz) =1 for all x,z. Tis 
assumed to be independent of the pair (R,Z). 
The following random functions will be used to describe the state of the 
population: For individuals entering the population in the time interval (t-y,t), 
L(t-y,t,x), LH(t-y,t,x) and LD(t-y,t,x) denote the number of individuals, 
healthy individuals and diseased individuals, respectively, at exact time t+x. 
The cumulative number of diseased individuals in (t,t+x) is denoted N(t-y,t,x) 
if the individuals entered the population in (t-y,t) and N(t,t+x,x) if the 
individuals entered the population in (t,t+x). Realizations of the fIrst three 
functions can jump one step up or down, while realizations of the last two 
functions are non-decreasing and can only have jumps one step up. When 
x=o and y~oo it is shown in the Appendix at the end of the paper that L(t-
y,t,x)~L, LH(t-y,t,x)~LH and LD(t-y,t,x)~LD in distribution where the 
indices of L, LH and LD have been dropped because the distributions of the 
latter are stationary. Similarly, as y~oo N(t-y,t,x)+N(t,t+x,x)~N(x) in 
distribution, where the latter is stationary and only depends on x, the length 
of the interval. Thus, the following stationary random functions will be used: 
L = Number of individuals 
LH= Number of healthy individuals [1] 
LD= Number of diseased individuals 
N(x)= Cumulated number of diseased individuals during x time units 
For a non-recurrent disease it is natural to make the general definitions 
P='Size of the diseased population/Size of the population' and 1='Number of 
occurrences per unit time during a period/Size of the population at the 
beginning of the period'. In terms of expected values of the functions in [1], 
P and I may be formally defmed as 
P = E(LD) 1= E(N(x»/ x 
E(L) , E(LH) [2] 
A somewhat different defmition of I is obtained if the denominator in [2] 
is replaced by E(L) (cf. [ELA 80], pp.32-35). This is less adequate when I is 
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intended to be a measure of the rate of new occurrences. It is also evident that 
E(LH) shall not include recovered individuals for non-mortal diseases. 
3. Some general expressions for prevalence and incidence 
The following expressions can be derived for the expectations of the 
random functions in [1] (cf. the Appendix at the end of the paper): 
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A J ST (U)(Sz (u) + ] SR (u- zlz)dFz (Z))dU (mortal diseases) 
E(L)= ~) () 
A f ST (u)du = A' E(T) (non -mortal diseases) [3a] 
() 
<XI 
E(LH)=Af ST(u)Sz(u)du 
o 
<XI u 
E(LD) = A f ST (u) f SR (u-zlz)dFz (z)du 
o 0 
<XI 
E(N(x)) = A f ST (u)dFz (u)·x 
o 
[3b] 
[3c] 
[3d] 
In [3b], E(LH) remains the same for mortal and non-mortal diseases 
(recovered individuals are not included in E(LH)). This also holds for E(LD). 
When the density function fz(x) exists, dFzCx) is replaced by fz(z)dz. 
The expressions in [3] inserted into [2] give P and I. The calculation of 
these quantities requires knowledge about the sf ST(X) which may not be 
feasible. It is often easier to get information about the times spent in the 
population from a cross sectional sample. These are realizations of the 
backward recurrence time, say V, with density fv(x)=ST(x)/E(T) ([COX 65], 
p. 356). In terms of the latter, P for a non-mortal disease can be expressed in 
the following way: 
<XI U 
Pnm = f Iv (u) f SR (u-zlz)dFz (z)du [4] 
o 0 
When the disease is mortal for a proportion PM of the population, P for the 
total population becomes 
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p _ Pnm 
w, - [J fv(u)Sz (u)du+ p"m }M + 1-PM [5] 
For both mortal and non-mortal diseases 
0() f Iv (u)dFz (u) 
1 = _0"--____ _ 
0() 
[6] 
f Iv (u)Sz (u)du 
° 
3.1. Cohort-specific P and 1, probability and hazard 
P and I are sometimes used synonymously with cumulative probability 
and hazard, respectively. To show the relations between the latter cocepts 
and P and I in open dynamic populations, consider a cohort of individuals 
entering the population in the time interval (t-y,t). The cohort-specific P(x) 
and l(x) , expressed as functions ofx= time spent in the population, are 
E(LD(t - y, t, t + x)) 
P(x) = and 
E(L(t-y,t,t+x)) 
lim [E(N(t-y,t,x+h))-E(N(t-y,t,x))]1 h 
l(x) = 
h ~ 0 E(LH(t- y,t,t+x)) 
where all expectations are obtained from the expressions in the Appendix. By 
letting y~O it is seen that 
J SR(x-zlz)dFz(z) 
----"-0 -x------- (mortal diseases) 
P(x)~ Sz(x)+ f Sn(x-zlz)dFz(z) 
x f Sn(x-zlz)dFz(z) (non-mortal diseases) 
° 
l(x) ~ _x_-=f:....::.z....:..(x-.:.) __ _ 
1-f SR (x -zlz)dFz (z) 
o 
Thus, P(x) and l(x) reduces to cumulative probability FzCx) and hazard 
fz(z)lSz(x) when Six I z)=l, but not in general. 
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3.2. Screening-related P and J 
The results in [3a]-[3d] describe the outcome in a population where the 
states of the individuals are continuously supervised. When the health states 
of the individuals are examined at discrete times, say at screenings performed 
every s:th year, then it can only be assessed whether the onset of the disease 
has occurred during the preceeding screening interval or not. Provided that 
all disease states are correctly classified (sensitivity and specificity are 1), the 
random variable Z has now to be replaced by ZD, where ZD=is for is-i<Zsis, 
i=1,2, .... By inserting ZD for Z in [4]-[6] one obtaines, after integration by 
parts, the following expressions for screening-related P and I: 
00 
Pnm(s)= ~]Fz(iS)-Fz(is-s)H fV(U)SR(U-islis)du [7] 
i2:1 is 
P ( ) = Pnm (s) 
,",' [~[Fz (")- FZ (" -,) ]Fv (")+ Pom (,)+ Sz (00) )PM + [- PM 
[8] 
~] FZ (is)-FZ (is -s)]Jv (is) 
J(S) = i>1 
~)Fz (is)- FZ (is-s)]Fv (is)+SZ (00) 
[9] 
i2:1 
3.3. Illustrations of the results 
Only for the purpose of illustrating the results, consider the following 
situation: The cross section of times spent in the population have the density 
fv(x) =exp(-xi f.1v)/ f.1v , where f.1v is the mean. The times from the entrance into 
the population until the onset of the disease have the cdf Fz(x)=1r(I-exp(-
x1f.1d), where 7r=Fz(ro) is the probability that an individual will eventually be 
diseased. The two functions fv(x) and Fz(x) are plotted in Figure 1 when 
f.1v=f.1z=lO and 7r=O.2 . For simplicity, only the case when the disease is 
mortal for a proportion PM of the population is considered. The sf of the times 
to death from the onset of the disease is SR(xlz)=exp(-xlf.1J independently of 
z, where f.1R is the mean. 
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Figure 1. Decreasing curve.The relative frequencies of times spent in the 
population for a cross section of individuals, given by 
fv (x) = exp(-x 110) 110. Increasing curve: Cumulated risk of the disease, 
increasing with time spent in the population, given by 
Fz (x) = 0.2(1-exp( -x I 10)). 
From (4) - (6) one obtains 
~Ol = ( )( fC ) , 1= (fC) 
1 flv 1 flz flv flz + 1-fC flv +- +- -fC·Pu·-
fl R fl v fl R 
For instance, if 1(=0.2 and flz=flv=10 then 1=0.011, and if furthermore 
PM=0.9 and flR=5 then Ptot=0.050. Notice that Ptot-fO as flR-fO, while 
Ptot --,>Jr(l + flz I flv r 1 as flR--'>CXJ, the largest value of the prevalence. 
Now, consider the screening-related P and I. The infmite sums in [8] and 
[9] can can be expressed 
~OI(S)={PM(l+_l_(_l +_1 ))+(1-PU)(l+~) (g(s)-l) }-l 
I(s) flv fln fC fln (exp(slflz)-l) 
I (s ) = fC( exp (s I fl z ) - 1 ) 
flv (g(s)-l- fC( exp(s I flz )-1)) 
where g(s) = exp(s(1/ flz + 1/ flv)). 
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I(s) and Ptols) are shown in Figure 2 as functions of s when 
1{ = O. 2, Jl z = Jl v = 10, Jl R = 5 and PM = O. 9. 
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Figure 2. Screening-related P (upper curve) and I (lower curve) in the 
illustrative example. 
When the screening interval s tends to zero, I(s) and P(s) tend to I and P, 
respectively. With increasing screening interval, I(s) and P(s) will decrease 
as a result of the fact that diseased induviduals will leave the population 
without being detected. Notice the roughly linear behaviour of the two 
functions. 
4. Optimized sceduling of screenings 
When the population consists of subgroups with different P's and I's, the 
problem arises of how to chose the screening interval s within each subgroup 
in order to maximize the total proportion of detected cases. Evidently, 
subgroups with high P or I should be screened more often. Here, a solution of 
the problem will be given which is based on the assumption that P and I are 
roughly linear functions of the screening interval s (cf. Figure 2.). 
Let 7ri be the proportion of the i:th subgroup and let ai - hisi be the 
corresponding I, assumed to be linear and based on the screening interval Si. 
The total I in the population is 
[10] 
Assume further that resources are limited, so only a fraction p of the total 
population can be screened every year. With N j individuals in the i:th 
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subgroup, this means that (N/s) from the latter can be screened every year 
andp= L(Ni I sdlLNi' or 
i i 
[11 ] 
Maximizing [10] with respect to the Sj'S , subject to [11] yields the 
optimal solutions of the screening intervals 
With equal screening intervals, Sj =s for all subgroups and in this case 
L ,,;b; 
I ". S=-, andI(s ... s ... )= L..J,,;a; _-,-1 __ 
P P 
[12] 
[13] 
The gain by using optimal rather than equal screening intervals can be 
judged by comparing the different expressions for I in [12] and [13]. Similar 
results can be derived for P, provided that the latter is linearly decreasing 
with s. 
Above, a linear form for I was assumed. One may instead maximize e.g. 
polynomials of the second order subject to [11], but the linear form is simpler 
and has been found to be realistic in many practical situations. How P and I 
can be estimated in practice from screening data is demonstrated in the next 
section. 
5. An application: Screening for diabetic retinopathy 
Proliferative diabetic retinopathy (PDR) is a disease among diabetic 
patients which unlikely is detected without screening [SUS 82]. A total 
number of 700 patients with type 1 diabetes mellitus were screened for PDR 
at Sahlgren's Hospital, Gothenburg, Sweden [KAL 93]. Two groups of 
patients at risk of PDR were identified: 90% with no- or background 
retinopathy (O-BDR) and 10% with pre-PDR (pre-PDR). The estimated risk 
of developing PDR, i.e. estimates of Fz (x), for the two groups is shown in 
Figure 3. The risk increases with the duration of the diabetes above 10 years, 
and the risk is roughly 4-5 times higher for patients with pre-PDR. Figure 4 
shows a histogram based on a cross section of 699 durations spent in the risk 
set. This histogram will be used as an estimate of fv(x) in both subgroups 
since it was not possible to obtain separate histograms for the two subgroups 
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from the available data set. Neither it was possible to estimate the function 
SR(xlz) from the data and therefor PDR will be considered as a disease which 
is non-mortal with SR (xlz)=1 for all x,z. In this case the expressions in [7] 
and [9] simplifies: 
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Pnm (s) = 2]Fz (is)-Fz (is-s)]Sv (is), [14] 
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i~l 
L [ F (is) - Fz (is - s) ].t;, (is) 
J(s) = ---------
l-PnmCs) 
.J .......  
,r'-.i 
r 
" .. rr.1' 
, .. ,.r.i 
,J 
20 30 40 50 
x 
[15] 
60 
Figure 3. Cumulated risk of PDRwith increasing duration of diabetes for 
the O-BDR group (lower curve) and for the pre-PDR group (upper curve) 
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Figure 4. Histogram (relative frequency within intervals of one year) 
showing the duration of diabetes in a cross section 699 patients. 
The computation of Pnrn(s) and l(s) from the empirical estimates of Fz(x) 
and fv(x) shown in Figure 3 and 4 are somewhat heavy and require the use of 
a computer. Figure 5 and 6 show the estimates ofPnrn(s) and l(s) for the two 
groups of patients. The computations were carried out for 1:O:;s:O:;lO, performed 
by a program written in SAS® (which can be offerred from the author on 
request). 
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Figure 5. Estimated sreening-related prevalence, P"m(s)' for the O-BDR 
group (lower curve) and for the pre-PDR group (upper curve). 
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Figure 6. Estimated screening-related incidence, I(s), for the O-BDR group 
(lower curve) andfor the pre-PDR group (upper curve). 
Estimated straight lines are 
{ 
(42-1.8s)·10-3 for O-BDR 
P(s)= (175-7.5s)-1003 for pre- PDR 
{
(4-0.14S).1O-3 for O-BDR 
I(s) = (22 - O. 9s)·10 03 for pre- PDR 
Estimates of the "true" values of P and I, which would have been obtained 
with continuous screening, are obtained by putting s=O in the estimated 
straight lines. The optimal screening intervals for the two groups, determined 
from [12] are s*=1.10/p for O-BDR and s* =0.54/p for pre-PDR. In the latter, 
the coefficients from P( s) were used. The coefficients from I( s) give roughly 
the same answer: Patients with pre-PDR should be screened roughly twice as 
often as patients with O-BDR in order to maximize the total number of 
detected cases in the total population. This advice should be regarded as a 
general recommendation used for the planning of the screenings. The final 
choice of screening intervals will depend on p, i.e. on the resources available 
at the hospital, and on individual risks. 
6. Conclusions 
It has been shown how prevalence and incidence in open dynamic 
populations can be estimated from screenings. The results are especially 
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useful in countries with limited medical resources, where screening 
examinations often are the only way of receiving knowledge about the true 
medical state of the population, but also in countries where medical resources 
are believed to be sufficient. In the latter, there is still a hugh spectrum of 
diseases which in most cases only can be detected by screening 
examinations, such as diabetic retinopathy and many neuronial diseases. 
It has also been shown how screenings can be planned to achieve optimal 
solutions under limited resources. These results can be used to reduce the 
costs and sti II maintain the quality of a screening study. 
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APPENDIX 
Some fundamental results for the functions describing the state of the 
population 
14 
The derivations make use of the following lemma about Poisson shot 
noice processes (cf. Papoulis, 1965, pp. 562-576): 
Lemma Let At (x) be the counting function on the time interval (t.t+x) of a 
Poisson process with intensity A and let {Ui } be the sequence of times 
measured from t until the i:th event occurs. Put 
( ) {
I with probability p(x - Ui ) o x-U = 
1 0 -"- l-p(x-Ui ) 
x 
Then L o( x - Ui ) has a Poisson distribution with meanA f p( u )du. 
i,,;,A,(x) 0 
To prove the relations in [3a], notice that L = L o(y - Ui ) as Y -+ 00. 
i";'A,_y(y) 
For non-mortal diseases, o(y-UJ=} if T;>y-U; and thus, 
p(u)=P(T;>u)=SJu). For mortal diseases, o(y-UJ=} if min(T;"Z;+R;»y-U;. 
and from this it follows that p(u) = P(min(T; ,Z;+R;»u)= SrCU)SZ+R(U), where 
u 
Sz+iu)=P(Z+R>u,Z>u)+P(Z+R>u, Z,::>u)=Sz (u)+ f SR (u-zJz)dFz (z). 
o 
LH can be represented in a similar way as L, but now o(y-UJ=) if T;>y-
U; and Z;>y-U; . Since p(u)=P(T; >u,Z;>u)=SrCu)Siu), [3b] follows. [3c] is 
proved analogously. 
In [3d] N(x) =N(t-y,t,x)+N(t,t+x,x) as y-+oo, where the latter two terms 
are defmed in Section 2. Now, 
N(t-y,t,x)= 
N(t,t+x,x)= 
Lo(x-U;), where o(x-U;)= 1 if I; >Z; andZ; <x-U; 
i::;At(x) 
From the Lemma it now follows that the expectation ofN(x) is 
co x+u x u 
A f f ST (z)dFz (Z)dU+A f f ST (z)dFz (z)du 
o u 0 0 
and it is easily veryfied that the expression above is the same as the one in 
[3d]. 
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